M & As this week: Bioverativ Therapeutics, Horizon Pharma
Bioverativ Therapeutics has reached an agreement to acquire clinical-stage biotechnology company True North Therapeutics.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Pharmaceuticals